Review Evidence

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already document the safety profile (readOnlyHint=true, idempotentHint=true, destructiveHint=false), and the description adds the behavioral fact that the response is deterministic and skeleton-shaped. However, it does not say what the skeleton response contains or how input is handled, leaving a partial transparency gap.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

One sentence with no filler; the core action and outcome are front-loaded. It is appropriately sized but terse to the point of vagueness, so not a full 5.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given a nested input schema and no output schema, the description is too thin: it does not explain the return shape, what 'Phase 1' means, or what evidence metadata is expected. Annotations cover safety but not operational context needed to invoke correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 0%, so the description needed to compensate for parameter meaning, but it mentions no parameter names or semantics. The schema itself provides constraints and enums, but the tool description contributes nothing to clarify reviewId, objective, evidence, or limits.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses a concrete verb-resource pair ('Accept Phase 1 evidence review metadata') and names the outcome ('return a deterministic skeleton response'), so an agent can tell this is a submission/stub endpoint for the review workflow. However, 'skeleton response' is unexplained and there is no sibling differentiation, though no siblings are listed.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives no guidance about when to call this tool versus any alternative, no workflow conditions, and no preconditions or exclusions. The only hint is the phrase 'Phase 1,' which is not elaborated.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.